|
ZBTB25 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13419999999243E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.6549999999913E-06 |
| Normal-vs-Stage2 |
5.124500E-03 |
| Normal-vs-Stage3 |
7.440200E-03 |
| Normal-vs-Stage4 |
7.774300E-02 |
| Stage1-vs-Stage2 |
8.794800E-01 |
| Stage1-vs-Stage3 |
1.694450E-01 |
| Stage1-vs-Stage4 |
9.231700E-02 |
| Stage2-vs-Stage3 |
4.041000E-01 |
| Stage2-vs-Stage4 |
2.635000E-01 |
| Stage3-vs-Stage4 |
6.259200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.65159999999864E-05 |
| Normal-vs-AfricanAmerican |
2.106400E-02 |
| Normal-vs-Asian |
3.219500E-04 |
| Caucasian-vs-AfricanAmerican |
6.348000E-01 |
| Caucasian-vs-Asian |
1.276790E-01 |
| AfricanAmerican-vs-Asian |
5.701900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.2172000000027E-05 |
| Normal-vs-Female |
2.407700E-04 |
| Male-vs-Female |
9.808400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.724800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.67560000003042E-06 |
| Normal-vs-Age(61-80Yrs) |
7.624500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.140020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.838300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.065000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.800800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.132810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.266600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.604600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.564200E-03 |
| Normal-vs-Grade 2 |
2.82590000000305E-06 |
| Normal-vs-Grade 3 |
7.794400E-04 |
| Normal-vs-Grade 4 |
2.018600E-01 |
| Grade 1-vs-Grade 2 |
3.260100E-02 |
| Grade 1-vs-Grade 3 |
1.386490E-02 |
| Grade 1-vs-Grade 4 |
4.020100E-03 |
| Grade 2-vs-Grade 3 |
2.342400E-01 |
| Grade 2-vs-Grade 4 |
2.603600E-02 |
| Grade 3-vs-Grade 4 |
1.903190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.22310000700332E-09 |
| Normal-vs-ccB subtype |
2.911900E-02 |
| ccA subtype-vs-ccB subtype |
3.001000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.9217999999972E-05 |
| Normal-vs-N1 |
1.709610E-01 |
| N0-vs-N1 |
5.024400E-04 |
|
|
